CH556318A - Verfahren zur herstellung der d-2-(6-methoxy-2-naphthyl)- propionsaeure. - Google Patents

Verfahren zur herstellung der d-2-(6-methoxy-2-naphthyl)- propionsaeure.

Info

Publication number: CH556318A
Authority: CH; Switzerland
Prior art keywords: naphthyl; methoxy; propionic acid; solution; iodide
Prior art date: 1969-09-30

Application number

CH1600073A

Other languages

German (de)

English (en)

Original Assignee

Syntex Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1969-09-30

Filing date

1970-08-18

Publication date

1974-11-29

1970-08-18 Application filed by Syntex Corp filed Critical Syntex Corp

1974-11-29 Publication of CH556318A publication Critical patent/CH556318A/de

Links

CMWTZPSULFXXJA-UHFFFAOYSA-N 2-(6-methoxy-2-naphthalenyl)propanoic acid Chemical compound C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 title claims abstract description 5
229940035676 analgesics Drugs 0.000 title abstract 2
239000000730 antalgic agent Substances 0.000 title abstract 2
239000002260 anti-inflammatory agent Substances 0.000 title abstract 2
229940121363 anti-inflammatory agent Drugs 0.000 title abstract 2
230000001754 anti-pyretic effect Effects 0.000 title abstract 2
239000002221 antipyretic Substances 0.000 title abstract 2
229940125716 antipyretic agent Drugs 0.000 title abstract 2
238000000034 method Methods 0.000 claims abstract description 23
125000000217 alkyl group Chemical group 0.000 claims abstract description 16
150000002148 esters Chemical class 0.000 claims abstract description 8
239000002904 solvent Substances 0.000 claims abstract description 8
239000002253 acid Substances 0.000 claims abstract description 5
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 33
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 24
XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims description 16
XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Substances CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 15
239000000203 mixture Substances 0.000 claims description 14
239000011541 reaction mixture Substances 0.000 claims description 13
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 12
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 12
150000001875 compounds Chemical class 0.000 claims description 11
-1 lithium carbonate Chemical class 0.000 claims description 10
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 9
125000003710 aryl alkyl group Chemical group 0.000 claims description 9
125000004432 carbon atom Chemical group C* 0.000 claims description 9
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
KMPWYEUPVWOPIM-KODHJQJWSA-N cinchonidine Chemical compound C1=CC=C2C([C@H]([C@H]3[N@]4CC[C@H]([C@H](C4)C=C)C3)O)=CC=NC2=C1 KMPWYEUPVWOPIM-KODHJQJWSA-N 0.000 claims description 8
230000003287 optical effect Effects 0.000 claims description 8
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 8
125000001453 quaternary ammonium group Chemical group 0.000 claims description 8
229940107816 ammonium iodide Drugs 0.000 claims description 7
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 6
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 6
KMPWYEUPVWOPIM-UHFFFAOYSA-N cinchonidine Natural products C1=CC=C2C(C(C3N4CCC(C(C4)C=C)C3)O)=CC=NC2=C1 KMPWYEUPVWOPIM-UHFFFAOYSA-N 0.000 claims description 6
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 6
150000003839 salts Chemical class 0.000 claims description 6
238000003756 stirring Methods 0.000 claims description 6
125000003342 alkenyl group Chemical group 0.000 claims description 5
229910001509 metal bromide Inorganic materials 0.000 claims description 5
CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 claims description 5
XWJUDDGELKXYNO-UHFFFAOYSA-N o-desmethylnaproxen Chemical compound C1=C(O)C=CC2=CC(C(C(O)=O)C)=CC=C21 XWJUDDGELKXYNO-UHFFFAOYSA-N 0.000 claims description 5
235000019260 propionic acid Nutrition 0.000 claims description 5
IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims description 5
INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 claims description 4
HSZCZNFXUDYRKD-UHFFFAOYSA-M lithium iodide Chemical compound [Li+].[I-] HSZCZNFXUDYRKD-UHFFFAOYSA-M 0.000 claims description 4
229910001511 metal iodide Inorganic materials 0.000 claims description 4
229910000027 potassium carbonate Inorganic materials 0.000 claims description 4
238000002360 preparation method Methods 0.000 claims description 4
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 3
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 3
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 3
FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 3
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 3
HOPRXXXSABQWAV-UHFFFAOYSA-N anhydrous collidine Natural products CC1=CC=NC(C)=C1C HOPRXXXSABQWAV-UHFFFAOYSA-N 0.000 claims description 3
229910052788 barium Inorganic materials 0.000 claims description 3
DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 claims description 3
150000001649 bromium compounds Chemical class 0.000 claims description 3
229910052791 calcium Inorganic materials 0.000 claims description 3
239000011575 calcium Substances 0.000 claims description 3
UTBIMNXEDGNJFE-UHFFFAOYSA-N collidine Natural products CC1=CC=C(C)C(C)=N1 UTBIMNXEDGNJFE-UHFFFAOYSA-N 0.000 claims description 3
125000005265 dialkylamine group Chemical group 0.000 claims description 3
238000001640 fractional crystallisation Methods 0.000 claims description 3
239000012442 inert solvent Substances 0.000 claims description 3
229910052744 lithium Inorganic materials 0.000 claims description 3
229910052749 magnesium Inorganic materials 0.000 claims description 3
239000011777 magnesium Substances 0.000 claims description 3
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
229910052759 nickel Inorganic materials 0.000 claims description 3
229910052700 potassium Inorganic materials 0.000 claims description 3
239000011591 potassium Substances 0.000 claims description 3
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 3
229910052708 sodium Inorganic materials 0.000 claims description 3
239000011734 sodium Substances 0.000 claims description 3
GFYHSKONPJXCDE-UHFFFAOYSA-N sym-collidine Natural products CC1=CN=C(C)C(C)=C1 GFYHSKONPJXCDE-UHFFFAOYSA-N 0.000 claims description 3
125000005270 trialkylamine group Chemical group 0.000 claims description 3
229910052725 zinc Inorganic materials 0.000 claims description 3
239000011701 zinc Substances 0.000 claims description 3
CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims description 2
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 2
230000015556 catabolic process Effects 0.000 claims description 2
239000013078 crystal Substances 0.000 claims description 2
238000006731 degradation reaction Methods 0.000 claims description 2
230000001419 dependent effect Effects 0.000 claims description 2
239000000706 filtrate Substances 0.000 claims description 2
XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 claims description 2
229910052808 lithium carbonate Inorganic materials 0.000 claims description 2
ZFYFBPCRUQZGJE-UHFFFAOYSA-N methyl 2-(6-methoxynaphthalen-2-yl)propanoate Chemical compound C1=C(OC)C=CC2=CC(C(C)C(=O)OC)=CC=C21 ZFYFBPCRUQZGJE-UHFFFAOYSA-N 0.000 claims description 2
230000007935 neutral effect Effects 0.000 claims description 2
150000002825 nitriles Chemical class 0.000 claims description 2
238000010992 reflux Methods 0.000 claims description 2
229910052938 sodium sulfate Inorganic materials 0.000 claims description 2
235000011152 sodium sulphate Nutrition 0.000 claims description 2
230000009089 cytolysis Effects 0.000 claims 1
208000002193 Pain Diseases 0.000 abstract description 2
230000003110 anti-inflammatory effect Effects 0.000 abstract description 2
125000003368 amide group Chemical group 0.000 abstract 1
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
206010061218 Inflammation Diseases 0.000 description 3
230000004054 inflammatory process Effects 0.000 description 3
WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
NBBJYMSMWIIQGU-UHFFFAOYSA-N Propionic aldehyde Chemical compound CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
125000003118 aryl group Chemical group 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
150000004820 halides Chemical class 0.000 description 2
229910052751 metal Inorganic materials 0.000 description 2
239000002184 metal Substances 0.000 description 2
229910001507 metal halide Inorganic materials 0.000 description 2
150000005309 metal halides Chemical class 0.000 description 2
125000001624 naphthyl group Chemical group 0.000 description 2
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
238000000926 separation method Methods 0.000 description 2
JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 1
125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
125000000590 4-methylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
208000010392 Bone Fractures Diseases 0.000 description 1
208000034656 Contusions Diseases 0.000 description 1
201000005569 Gout Diseases 0.000 description 1
208000034693 Laceration Diseases 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
206010037660 Pyrexia Diseases 0.000 description 1
125000003545 alkoxy group Chemical group 0.000 description 1
229910000147 aluminium phosphate Inorganic materials 0.000 description 1
230000001760 anti-analgesic effect Effects 0.000 description 1
206010003246 arthritis Diseases 0.000 description 1
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
238000006065 biodegradation reaction Methods 0.000 description 1
238000009835 boiling Methods 0.000 description 1
ZTQSAGDEMFDKMZ-UHFFFAOYSA-N butyric aldehyde Natural products CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 1
230000009519 contusion Effects 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
230000000694 effects Effects 0.000 description 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
229910052736 halogen Inorganic materials 0.000 description 1
150000002367 halogens Chemical class 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
230000003301 hydrolyzing effect Effects 0.000 description 1
125000004356 hydroxy functional group Chemical group O* 0.000 description 1
150000004694 iodide salts Chemical group 0.000 description 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
150000007522 mineralic acids Chemical class 0.000 description 1
NNNLDUINFHSKNG-UHFFFAOYSA-N n-[2-(6-methoxynaphthalen-2-yl)propylidene]hydroxylamine Chemical compound C1=C(C(C)C=NO)C=CC2=CC(OC)=CC=C21 NNNLDUINFHSKNG-UHFFFAOYSA-N 0.000 description 1
125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 1
125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
125000004344 phenylpropyl group Chemical group 0.000 description 1
239000002243 precursor Substances 0.000 description 1
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
230000035484 reaction time Effects 0.000 description 1
210000002027 skeletal muscle Anatomy 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

CH1600073A 1969-09-30 1970-08-18 Verfahren zur herstellung der d-2-(6-methoxy-2-naphthyl)- propionsaeure. CH556318A (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US86246969A	1969-09-30	1969-09-30

Publications (1)

Publication Number	Publication Date
CH556318A true CH556318A (de)	1974-11-29

Family

ID=25338569

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CH1600073A CH556318A (de)	1969-09-30	1970-08-18	Verfahren zur herstellung der d-2-(6-methoxy-2-naphthyl)- propionsaeure.

Country Status (2)

Country	Link
CH (1)	CH556318A (es)
ES (1)	ES410141A1 (es)

1970
- 1970-08-18 CH CH1600073A patent/CH556318A/de not_active IP Right Cessation
1972
- 1972-12-29 ES ES410141A patent/ES410141A1/es not_active Expired

Also Published As

Publication number	Publication date
ES410141A1 (es)	1976-01-01

Legal Events

Date	Code	Title	Description
1982-08-13	PUE	Assignment	Owner name: SYNTEX PHARMACEUTICALS INTERNATIONAL LIMITED
1990-10-31	PL	Patent ceased

Publication	Publication Date	Title
DE1518528C3 (es)	1974-12-05
DE1670849C3 (de)	1978-07-20	Verfahren zur Herstellung von 8-Acylamino-1,23,4-tetrahydroisochinolinen
DE2159011C3 (de)	1981-09-17	Verfahren zur Herstellung von 2-(6-Methoxy-2-naphthyl)-propionsäure und Di-(6 methoxy-2-naphthyl)zink und 6-Methoxy-2-naphthylzinkhalogenid
DE2241012A1 (de)	1973-03-15	Neue 3,1-benzoxazin-4-on-derivate und verfahren zur herstellung derselben
DE1021846B (de)	1958-01-02	Verfahren zur Herstellung von ª‡,ª‡-Diphenyl-ª‰-(tert. -amino)-propanolen
DE2322932A1 (de)	1973-11-22	Verfahren zur herstellung von 2-(6methoxy-2-naphthyl)-propionsaeure
CH548358A (de)	1974-04-30	Verfahren zur herstellung der d-2-(6-methoxy-2-naphthyl)-propionsaeure.
CH550761A (de)	1974-06-28	Verfahren zur herstellung der d-2-(6-methoxy-2-naphthyl)-propionsaeure.
DE2629599A1 (de)	1977-06-02	Beta-sulfenylacrylsaeure-verbindungen und verfahren zu ihrer herstellung
CH548356A (de)	1974-04-30	Verfahren zur herstellung der d-2-(6-methoxy-2-naphthyl)-propionsaeure.
CH550762A (de)	1974-06-28	Verfahren zur herstellung der d-2-(6-methoxy-2-naphthyl)-propionsaeure.
CH555311A (de)	1974-10-31	Verfahren zur herstellung der d-2-(6-methoxy-2-naphthyl) -propionsaeure.
CH556810A (de)	1974-12-13	Verfahren zur herstellung der d-2-(6-methoxy-2-naphthyl)-propionsaeure.
AT220609B (de)	1962-04-10	Verfahren zur Herstellung von neuen Dibenzo-cycloheptaen-Verbindungen und deren salzartigen Abkömmlingen
CH556809A (de)	1974-12-13	Verfahren zur herstellung der d-2-(6-methoxy-2-naphthyl)-propionsaeure.
CH550760A (de)	1974-06-28	Verfahren zur herstellung der d-2-(6-methoxy-2-naphthyl)-propionsaeure.
AT218509B (de)	1961-12-11	Verfahren zur Herstellung von basisch substituierten Carbinolen, sowie von ihren sterisch einheitlichen Razematen und deren optisch aktiven Komponenten und/oder ihren Säureadditionssalzen
DE1292660B (de)	1969-04-17	Verfahren zur Herstellung von p-(Bis-ª‰-chloraethyl-amino)-phenylalanin-hydrochlorid
CH550759A (de)	1974-06-28	Verfahren zur herstellung der d-2-(6-methoxy-2-naphthyl)-propionsaeure.
DE3420387A1 (de)	1984-12-06	2-(4-biphenylyl)-4-hexenonsaeure und ihre derivate mit entzuendungshemmender wirksamkeit
CH553147A (de)	1974-08-30	Verfahren zur herstellung von 2-(6-methoxy-2-naphthyl)propionsaeure und 2-(6-methoxy-2-naphthyl)-1-propanol.
DE1088972B (de)	1960-09-15	Verfahren zur Herstellung von ª†, ª†, ª†-Triphenylpropylaminen
DE946145C (de)	1956-07-26	Verfahren zur Herstellung von Alkyl- bzw. Alkoxalkylaminobenzoesaeureestern
CH548361A (de)	1974-04-30	Verfahren zur herstellung der d-2-(6-methoxy-2-nphthyl)-propionsaeure.
CH550765A (de)	1974-06-28	Verfahren zur herstellung der d-2-(6-methoxy-2-naphthyl)-propionsaeure oder der d-2-(5-halogen-6-methoxy2-naphthyl)-propionsaeuren.